Characteristics | Favorable outcome(n = 175, 0–2) | Poor outcome (n = 114, 3–6) | P value |
---|---|---|---|
Age(years) | 54.00 | 58.00 | 0.013c |
Mean (SD) | (48.00–61.00) | (50.75-64.00) | |
Gender | |||
 Male | 120(68.6%) | 75(65.6%) | 0.622b |
 Female | 55(31.4%) | 39(34.4%) | |
ICH score | |||
 0(0–1) | 152(86.9%) | 64(56.1%) | < 0.001b |
 1(2–4) | 23(13.1%) | 50(43.9%) | |
Cerebral hernia | 2(1.1%) | 10(8.8%) | 0.004a |
Hematoma expansion | 10(5.7%) | 14(12.3%) | 0.048a |
Intraventricular hemorrhage | 49(28.0%) | 45(39.5%) | 0.042b |
Surgery | 22(12.6%) | 47(41.2%) | < 0.001b |
Complication | |||
 infection | 35(20.0%) | 50(43.9%) | < 0.001b |
 epilepsy | 5(2.9%) | 6(5.3%) | |
 deep vein thrombosis | 7(4.0%) | 6(5.3%) | |
 hydrocephalus | 6(3.4%) | 4(3.5%) | |
Hypertension | 144(82.3%) | 92(80.7%) | 0.734b |
Diabetes | 18(10.3%) | 11(9.6%) | 0.860a |
Cerebral infarction | 6(3.4%) | 6(5.3%) | 0.445a |
Cerebral hemorrhage | 4(2.2%) | 5(4.4%) | 0.315a |
Smoking | 72(41.1%) | 52(45.6%) | 0.453b |
Drinking | 50(28.6%) | 37(32.5%) | 0.482b |
Basic diseases | |||
 cancer | 25(14.3%) | 10(8.8%) | 0.310b |
 lung diseases | 24(13.7%) | 8(7.0%) | |
 other diseases | 6(3.4%) | 6(5.3%) | |
GCS | 15.00(13.00–15.00) | 13.00(9.00–15.00) | < 0.001c |
Hospital stays(day) | 13.00(9.00–17.00) | 17.5(13.75-25.00) | < 0.001d |
Albumin(g/dL) | 4.24(3.98–4.50) | 4.21(3.91–4.45) | 0.249c |
Total cholesterol(mg/dL) | 4.62(4.00-5.29) | 4.52(3.85–5.06) | 0.061c |
C-reactive protein(mg/dL) | 2.03(0.79–4.08) | 2.14(0.85–7.39) | 0.191c |
Monocytes(10^9/L) | 0.40(0.29–0.57) | 0.45(0.31–0.70) | 0.074c |
Lymphocyte(10^9/L) | 1.17(0.92–1.52) | 1.00(0.72–1.36) | 0.002c |
Neutrophils(10^9/L) | 6.81(5.03–9.03) | 8.35(6.03–11.13) | 0.001c |
Hemoglobin(g/L) | 142.00(133.00-154.00) | 137.50(130.00-150.00) | 0.085c |
Platelet(10^9/L) | 196.00(153.00-239.00) | 192.50(145.75-239.25) | 0.453c |
COUNT | |||
 1 | 56(32.0%) | 26(22.8%) | 0.019d |
 2 | 109(62.3%) | 75(65.8%) | |
 3 | 10(5.7%) | 11(9.6%) | |
 4 | 0(0.0%) | 2(1.8%) | |
SIS | |||
 0 | 25(14.3%) | 7(6.1%) | 0.017d |
 1 | 119(68.0%) | 74(64.9%) | |
 2 | 31(17.7%) | 33(29.0%) | |
PNI | |||
 0 | 77(44.0%) | 72(63.2%) | 0.001d |
 1 | 98(56.0%) | 42(36.8%) |  |
 LMR | 2.97(2.05–4.22) | 2.28(1.50–3.37) | < 0.001c |
OPS | |||
 0 | 0(0.0%) | 0(0.0%) | < 0.001d |
 1 | 53(30.3%) | 26(22.8%) | |
 2 | 110(62.9%) | 60(52.6%) | |
 3 | 12(6.8%) | 28(34.4%) | |
NPS | |||
 0 | 4(2.3%) | 0(0.0%) | < 0.001d |
 1 | 21(12%) | 4(3.5%) | |
 2 | 76(43.4%) | 35(30.7%) | |
 3 | 54(30.9%) | 53(46.5%) | |
 4 | 20(11.4%) | 22(19.3%) |